Administrative Rules of Montana › Department 37 - PUBLIC HEALTH AND HUMAN SERVICES › Chapter 37.114 - COMMUNICABLE DISEASE CONTROL › Subchapter 37.114.1 - General Provisions › Rule 37.114.101 - DEFINITIONS

Current through Register Vol. 13, July 5, 2024
In addition to the definitions contained in
				  50-1-101,
				  MCA, unless otherwise indicated, the following definitions apply throughout
				  this chapter:
(1) "Case" means a
				person who is confirmed or suspected to have a reportable disease or condition
				as listed in ARM
				37.114.203.
(2) "Contact" means a person or animal that
				may have had an opportunity to acquire an infection due to the contact's
				association with a suspected or confirmed infected person or animal or a
				contaminated environment.
(3)
				"Contamination" means the presence of a disease-causing agent upon a living
				body surface or within or upon any inanimate article or substance.
(4) "Control of Communicable Diseases Manual"
				means the publication adopted and incorporated by reference in ARM
				37.114.105(1)(a).
(5) "Day care facility" has the meaning
				provided for under
				52-2-703,
				MCA.
(6) "Directly observed therapy
				(DOT)" means the method whereby a trained health care worker or another trained
				designated person watches a patient swallow each dose of antituberculosis
				medication and documents it. DOT can include electronic directly observed
				therapy (eDOT) utilizing a video conferencing application only with express
				permission from the state TB program.
(7) "Form" means a paper form or
				electronically submitted information consisting of data elements necessary to
				implement effective surveillance, investigation, or mitigation of reportable
				diseases and outbreaks.
(8) "
				Guideline for Isolation Precautions: Preventing Transmission of Infectious
				Agents in Healthcare Settings" means the publication adopted and incorporated
				by reference in ARM
				37.114.105(1)(b).
(9) "Health care" means health care as
				defined in
				50-16-504,
				MCA.
(10) "Health care facility" is
				a facility as defined in
				50-5-101,
				MCA.
(11) "Health care provider"
				means a health care provider as defined in
				50-16-504,
				MCA.
(12) "HIV infection" means
				infection with the human immunodeficiency virus.
(13) "Household contact" is a person or
				animal living within the household of an infected person.
(14) "Infected person" means a person who
				harbors an infectious agent whether or not illness is currently
				discernible.
(15) "Infection" means
				the entry and development or multiplication of an infectious agent in the body
				of man or animals.
(16) "Infection
				control precautions" means those measures necessary to prevent the transmission
				of disease from an infected person to another person, taking into consideration
				the specific suspected or confirmed communicable disease and the specific
				circumstances of the case. The infection control precautions required for a
				case admitted to a hospital or other health care facility are those measures
				identified as isolation precautions applicable to the specific disease in the "
				Guideline for Isolation Precautions: Preventing Transmission of Infectious
				Agents in Healthcare Settings" adopted and incorporated by reference in ARM
				37.114.105(1)(b).
				The infection control precautions required for a case not admitted to a
				hospital or other health care facility are those measures identified as methods
				of control applicable to the specific disease in the "Control of Communicable
				Diseases Manual", adopted and incorporated by reference in ARM
				37.114.105(1)(a).
				Infection control precautions are required, as stated in this rule, whether or
				not the person is subject to isolation.
(17) "Infectious agent" means an organism
				including virus, rickettsia, bacteria, fungus, protozoan, prion, or helminth
				that is capable of producing an infection or infectious disease.
(18) "Infectious disease" means a clinically
				manifest disease of man or animals resulting from an infection.
(19) "Infectious person" means a person from
				whom another person may acquire an infectious agent by touch or
				proximity.
(20) "Laboratory" means
				any facility or other area used by microbiological, serological, chemical,
				hematological, immunohematological, molecular, biophysical, cytological,
				pathological or other examinations of human body fluids, secretions,
				excretions, or excised or exfoliated tissues, for the purpose of providing
				information for the diagnosis, prevention or treatment of any human disease or
				impairment, for the assessment of human health.
(21) "Laboratory Professional" means any
				person who supervises or works in a laboratory.
(22) "Multidrug-Resistant Organisms (MDRO)"
				means microorganisms, predominantly bacteria, that are resistant to one or more
				classes of antimicrobial agents.
(23) "Outbreak" means the occurrence of more
				cases of a disease than would normally be expected in a specific place or group
				of people over a given period of time.
(24) "Potential outbreak" means the presence
				or suspected presence of a communicable disease in a population where the
				number of susceptible persons and the mode of transmission of the disease may
				cause further transmission of that disease.
(25) "Reportable disease" means any disease,
				the occurrence or suspected occurrence of which is required to be reported by
				ARM 37.114.203.
(26) "Sensitive
				occupation" means an occupation described in ARM
				37.114.301.
(27) "Sexually transmitted infection" means
				human immunodeficiency virus (HIV) infection, syphilis, gonorrhea, chancroid,
				lymphogranuloma venereum, granuloma inguinale, or all chlamydia trachomatis
				infections including chlamydial genital infections.
(28) "Sexually Transmitted Infections
				Treatment Guidelines" means the guidelines adopted and incorporated by
				reference in ARM
				37.114.105(1)(c).
(29) "Surveillance" means scrutiny of all
				aspects of occurrence and transmission of a disease that are pertinent to
				effective control.
(30)
				"Susceptible" means having insufficient resistance against a disease and likely
				to contract the disease if exposed.
(31) "Toxic Metals" means individual metals
				and metal compounds that may negatively affect an individual's health and shall
				include arsenic, cadmium, lead, and mercury for the purposes of these
				rules.
(32) "Youth camp" has the
				meaning provided for under
				50-52-101,
				MCA.
AUTH:
					 50-1-202,
					 50-2-116,
					 50-17-103,
					 MCA; IMP:
					 50-1-202,
					 50-17-103,
					 50-18-101,
					 MCA